CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!

被引：1
|
作者：
Cook-Sather, Scott D. [1 ]
Adamson, Peter C. [2 ]
Li, Jin [3 ,4 ]
Hakonarson, Hakon [3 ,4 ]
机构：
[1] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
来源：
ANESTHESIOLOGY | 2016年 / 125卷 / 06期
关键词：
IMPLEMENTATION CONSORTIUM GUIDELINES; N-DEMETHYLATION; CODEINE THERAPY; S-KETAMINE; PHARMACOGENETICS; GENOTYPES; CYP2B6; ALLELE;
D O I：
10.1097/ALN.0000000000001399
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [21] Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele
    Hwang, In Cheol
    Park, Ji Young
    Ahn, Hong Yup
    Kim, Kyoung Kon
    Suh, Heuy Sun
    Ko, Ki Dong
    Kim, Kyoung-Ah
    [J]. CLINICA CHIMICA ACTA, 2014, 428 : 77 - 81
  • [22] Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6
    Zhang, Kehan
    Li, Yilin
    Fu, Yao
    Cui, Tiantian
    Wang, Qian
    Mao, Xu
    Peng, Ying
    Zheng, Jiang
    [J]. CURRENT DRUG METABOLISM, 2021, 22 (11) : 882 - 892
  • [23] Differences in Methadone Metabolism by CYP2B6 Variants
    Gadel, Sarah
    Friedel, Christina
    Kharasch, Evan D.
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 994 - 1001
  • [24] The role of CYP2B6 in human xenobiotic metabolism
    Ekins, S
    Wrighton, SA
    [J]. DRUG METABOLISM REVIEWS, 1999, 31 (03) : 719 - 754
  • [25] Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
    D'Avolio, Antonio
    De Francia, Silvia
    Basile, Vittoria
    Cusato, Jessica
    De Martino, Francesca
    Pirro, Elisa
    Piccione, Francesca
    Ardito, Arianna
    Zaggia, Barbara
    Volante, Marco
    Di Perri, Giovanni
    Terzolo, Massimo
    [J]. PHARMACOGENETICS AND GENOMICS, 2013, 23 (06): : 293 - 300
  • [26] The effects of CYP2B6 inactivators on the metabolism of ciprofol
    Lu, Ming
    Zhang, Xiaorui
    Li, Wenli
    Li, Xiangchen
    Li, Shan
    Yin, Xiaoyu
    Zhang, Zhiqing
    [J]. PLOS ONE, 2024, 19 (07):
  • [27] Hepatic CYP2B6 expression:: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (Constitutive Androstane Receptor) expression
    Lamba, V
    Lamba, J
    Yasuda, K
    Strom, S
    Davila, J
    Hancock, ML
    Fackenthal, JD
    Rogan, PK
    Ring, B
    Wrighton, SA
    Schuetz, EG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03): : 906 - 922
  • [28] Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism
    Crane, Alice L.
    Klein, Kathrin
    Zanger, Ulrich M.
    Olson, James R.
    [J]. TOXICOLOGY, 2012, 293 (1-3) : 115 - 122
  • [29] Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles
    Gonzalo Restrepo, Juan
    Martinez, Carmen
    Garcia-Agundez, Augusto
    Gaviria, Elmer
    Julio Laguna, Jose
    Garcia-Martin, Elena
    Agundez, Jose A. G.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (12): : 773 - 778
  • [30] The CYP2B6*6 Allele Significantly Alters the N-Demethylation of Ketamine Enantiomers In Vitro
    Li, Yibai
    Coller, Janet K.
    Hutchinson, Mark R.
    Klein, Kathrin
    Zanger, Ulrich M.
    Stanley, Nathan J.
    Abell, Andrew D.
    Somogyi, Andrew A.
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (06) : 1264 - 1272
12345